Trial Details

TERMINATED
Basic Information
Clinical ID c4377
Identifier NCT00607971
Trial Title Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Constipation-Predominant Irritable Bowel Syndrome
Interventions DRUG: Renzapride
Participant Information
Sponsor Alizyme
City Huntsville
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2006-04
Primary Completion Date 2008-06
Completion Date 2008-06